Advancements in Nanoparticle-Based Adjuvants for Enhanced Tuberculosis Vaccination: A Review
Tuberculosis (TB) remains a leading cause of morbidity and mortality worldwide, necessitating the development of more effective vaccines. Nanoparticle-based adjuvants represent a promising approach to enhancing tuberculosis vaccine efficacy. This review focuses on the advantages of nanoparticulate-l...
Κύριοι συγγραφείς: | , , , , , |
---|---|
Μορφή: | Άρθρο |
Γλώσσα: | English |
Έκδοση: |
MDPI AG
2024-11-01
|
Σειρά: | Vaccines |
Θέματα: | |
Διαθέσιμο Online: | https://www.mdpi.com/2076-393X/12/12/1335 |